Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 177

Results For "expert"

1795 News Found

Borealis appoints IMCD as healthcare portfolio distributor
Supply Chain | July 13, 2021

Borealis appoints IMCD as healthcare portfolio distributor

The distribution agreement is effective from 1 October 2021 and applies to Bormed products used in pharmaceutical packaging, medical and diagnostic devices


Solara announces restoration of CEP for ranitidine hydrochloride
News | July 03, 2021

Solara announces restoration of CEP for ranitidine hydrochloride

Ranitidine Hydrochloride is an important product for Solara and is manufactured at its Cuddalore site


Sun Pharma launches 'Sunkalp' on National Doctors' Day
News | July 01, 2021

Sun Pharma launches 'Sunkalp' on National Doctors' Day

Sun Pharma has committed Rs. 100 crores towards these initiatives


Pharma majors collaborate for clinical trial of Molnupiravir for COVID-19
News | June 30, 2021

Pharma majors collaborate for clinical trial of Molnupiravir for COVID-19

The five pharma companies have entered into a collaboration agreement, wherein the parties will jointly sponsor, supervise and monitor the clinical trial in India


Zydus and Bayer announce extension of their JV
News | June 21, 2021

Zydus and Bayer announce extension of their JV

Bayer Zydus Pharma will continue to operate in core therapies with new products in the pipeline


Bayer acquires Noria and PSMA Therapeutics
News | June 07, 2021

Bayer acquires Noria and PSMA Therapeutics

Broadens company’s oncology platform of Targeted Alpha Therapies (TATs)


Govt. to procure 30 Cr COVID-19 vaccine doses from Biological-E
News | June 03, 2021

Govt. to procure 30 Cr COVID-19 vaccine doses from Biological-E

These vaccine doses will be manufactured and stockpiled by the company from August-December 2021


Nanoform and Celanese explore ways to enhance drug delivery
News | May 25, 2021

Nanoform and Celanese explore ways to enhance drug delivery

Nanoform and Celanese intend to work on formulation development, leveraging each organization's unique formulation expertise.


Gap between two doses of Covishield extended; No extension for Covaxin
News | May 14, 2021

Gap between two doses of Covishield extended; No extension for Covaxin

The COVID Working Group has recommended extension of the gap between the first and second doses of Covishield


COVAXIN phase II/III clinical trial approved for 2-18 years
News | May 13, 2021

COVAXIN phase II/III clinical trial approved for 2-18 years

BBIL had proposed to carry out Phase II/III clinical trial of Covaxin in the age group of 2 to 18 years